Subtype
Bone Neoplasm
CI-CAN-00000569Explore in graph →
Non-malignant65 active trials4 approved drugs16 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000569Explore in graph →
Clinical trials
342 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07820033 | Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial(PEARL RCT) | not yet recruiting | Phase 2 | 46 | University Health Network, TorontoOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT04433221 | Combination Immunotherapy Targeting Sarcomas | not yet recruiting | Phase 1 / Phase 2 | 20 | Shenzhen Geno-Immune Medical InstituteOTHER | 1 | Aug 26, 2026 |
| clinicaltrials |
| NCT07788300 | Surgical Outcomes of Extended Endoscopic Endonasal Approach for Skull Base Lesions. | not yet recruiting | N/A | 30 | Assiut UniversityOTHER | 1 | Aug 26, 2026 | clinicaltrials |
| NCT07729059 | "Exercise Intervention to Increase Physical Activity in Young Sarcoma Survivors (Sport Ist Herzenssache)" | not yet recruiting | N/A | 46 | Universität Duisburg-EssenOTHER | 0 | Jul 27, 2026 | clinicaltrials |
| NCT07707024 | Intraoperative Neuromonitoring of Sacral Reflexes to Predict Post Operative Function in Patients Undergoing Sacrectomy for Pelvic Bone Malignancy or Patients Undergoing Spinal Procedures Without Sacral Root Involvement | not yet recruiting | N/A | 50 | City of Hope Medical CenterOTHER | 1 | Jul 16, 2026 | clinicaltrials |
| NCT07619950 | EVERolimus and LenvAtinib Versus Everolimus for Bone Sarcoma | not yet recruiting | Phase 2 | 94 | Yonsei UniversityOTHER | 0 | Jun 2, 2026 | clinicaltrials |
| NCT07620431 | Neoadjuvant Radiotherapy and Surgery for High-Risk Localized Ewing Sarcoma | not yet recruiting | — | 55 | Peking University People's HospitalOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT07560410 | Treatment of Truncated ALK-positive Bone Cancer Using Crizotinib (Xalkori) or Alectinib (Alecensa) | not yet recruiting | Phase 1 / Phase 2 | 10 | China Medical University HospitalOTHER | 1 | May 11, 2026 | clinicaltrials |
| NCT07337018 | Evaluation of Tumor Resection and Reconstruction With Prosthetic Implants(RERIO) | not yet recruiting | — | 100 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 0 | Jan 13, 2026 | clinicaltrials |
| NCT07145931 | Neoadjuvant Immunochemotherapy and Postoperative Adjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma Invading the Skull Base | not yet recruiting | Phase 2 | 24 | Sun Yat-sen UniversityOTHER | 1 | Aug 28, 2025 | clinicaltrials |
| NCT06979115 | Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resection of Bone and Soft Tissue Tumors(ICG-BST) | not yet recruiting | — | 40 | Guangdong Provincial People's HospitalOTHER | 1 | May 18, 2025 | clinicaltrials |
| NCT06495580 | Optic Nerve Stimulation To Prevent Visual Deficits After Endoscopic Cranial Approaches | not yet recruiting | N/A | 20 | University of California, San FranciscoOTHER | 1 | Jul 12, 2024 | clinicaltrials |
| NCT06070259 | Insights Into Participating in Studies for Bone Cancer | not yet recruiting | — | 500 | Power Life Sciences Inc.INDUSTRY | 1 | Oct 6, 2023 | clinicaltrials |
| NCT05813665 | A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone | not yet recruiting | Phase 3 | 146 | Shanghai JMT-Bio Inc.INDUSTRY | 1 | Apr 19, 2023 | clinicaltrials |
| NCT05515068 | Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas(COSS-Registry) | not yet recruiting | — | 1,000 | Klinikum StuttgartOTHER | 0 | Aug 25, 2022 | clinicaltrials |
Data updated 15 days agoSource updated Sep 15, 2026source: clinicaltrials